Odyssey Thera compounding profiling service
Using cutting-edge Protein-fragment Complementation Assay technology from Odyssey Thera, Lonza is able to offer profiling services that can shape and influence critical decisions about drug candidates.
This unique cell-wide analysis platform broadly addresses target classes, signalling pathways and cellular processes. Classify drugs by comparison to an extensive compound database defining MOA and predicting safety threats.
It features: analysis of drug activity for any target class or pathway across cellular systems; high-content/high-throughput data capture and analysis; in-depth data interpretation including comparison to an extensive database of known drugs and toxicants; improved decision making throughout the development process.
Suitable applications include: target validation, HTS, SAR testing, toxicity and drug safety screens and compound selectivity testing.
Phone: 1300 657508
Navinci Diagnostics Naveni CD8/MHC-I Atto647N proximity ligation assay (PLA) kit
The Naveni CD8/MHC-I Atto647N is an in situ proximity ligation assay kit for the detection of the...
Invent Biotechnologies Minute Single Cell Nuclei Kits
The Invent Biotechnologies Minute Single Cell Nuclei Kits use proprietary spin column-based...
MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces and Fecal Preservation Solution
MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces is a magnetic bead-based solution...
Learn More
I am interested in Odyssey Thera compounding profiling service.
Complete the form and a supplier representative will be in touch.
